Allergan, Inc. (NYSE:AGN)

10 Companies with the Biggest 2016 Share Buybacks

As the U.S. economy clawed its way back from the depths of the financial crisis, the stock market recovered too, only more quickly. Partly that was because of public companies' ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CenterPoint, NetApp, NiSource, Nvidia, Orbital ATK, Weyerhaeuser and More

Stocks were indicated to open strong on Monday, with the Dow up almost 100 points and the S&P 500 up about 13 points. Even with the market being just under ...
Read Full Story »

Is Editas Facing a New Reality in CRISPR Land?

Editas Medicine Inc. (NASDAQ: EDIT) is one of the biotech and biohealth players that sits on the cusp of new technology and developments for the next major growth phase in ...
Read Full Story »

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse analyst Vamil Divan has released an outlook on the pharmaceutical sector. While the weighting for the sector is Market Weight, there are some positives in the call. The ...
Read Full Story »

JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017

One segment in the markets that has been dogged with issues for almost two years is the big pharmaceuticals, as numerous factors have kept the lid on share prices and, ...
Read Full Story »

4 UBS Large Cap Top Pick Dividend Growth Stocks to Buy Now

One of the disturbing trends about the ongoing market rally is that a small number of huge stocks are responsible for much of the gains, and that is reminiscent of the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Costco, Domino’s Pizza, Fortinet, Verizon, Yum Brands and More

After a huge Thursday in which the markets soared, the futures traded flat to modestly higher Friday morning. With earnings still coming in hot and heavy, many on Wall Street are ...
Read Full Story »

Huge Real Estate and Health Care Trades Highlight Insider Selling: Regency Centers, Allegan, UnitedHealthcare, Wyndham and More

In a week that offered up almost everything, and was completed by another outstanding nonfarm payroll report, the insider activity that had been heavily leaning toward the sellers started to ...
Read Full Story »
100 dollar bills

What to Expect From Major Companies Reporting Earnings on Wednesday

24/7 Wall St. has put together a preview of some of the most anticipated quarterly results due on Wednesday. The broad markets hit new highs on Tuesday, giving more credence ...
Read Full Story »
blue cart

5 Cheap Stocks to Buy From Merrill Lynch’s Focus List for a Very Expensive Market

In the euphoria of the long-awaited push through the 20,000 level on the Dow Jones Industrial Average, there is a potential train-wreck waiting to happen, and investors need to be ...
Read Full Story »
Unhealthy Person

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

When traders look at a stock at its highs and imagine what would be had they gotten in at the lows, the thought that invariably gets triggered is “At the ...
Read Full Story »
percentage button

Hedge Funds Dumped Allergan, Bought Procter & Gamble in Q3

Consumer staples represented the largest aggregate purchases among the top 50 hedge funds during the third quarter of 2016. The hedgies bought $12.2 billion worth of stock in consumer staples ...
Read Full Story »
investing

Hedge Funds Bought Apple, P&G in Q3; Dumped Allergan, Charter

Building on a turn toward more equity investments in the second quarter of this year, the top 50 hedge funds boosted their equity positions by 2.9% in the third quarter. ...
Read Full Story »
upside

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

If any sector has had a tough go of it the past year, it has been health care, and especially biotechnology. Continued harsh rhetoric from politicians, especially the Democrats, over ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: AbbVie, Chevron, Home Depot, Nike, Qualcomm, VMware and More

Stocks were up very slightly on Monday morning, but not enough to offset Friday's sell-off after the Clinton email situation was brought back front and center. The earnings floodgates are ...
Read Full Story »